Literature DB >> 35022572

MLKL ubiquitylation: more than a makeover.

Weihong Wang1,2, Yi-Nan Gong3,4.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35022572      PMCID: PMC8816916          DOI: 10.1038/s41418-022-00934-z

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   12.067


× No keyword cloud information.
  12 in total

1.  TAM Kinases Promote Necroptosis by Regulating Oligomerization of MLKL.

Authors:  Ayaz Najafov; Adnan K Mookhtiar; Hoang Son Luu; Alban Ordureau; Heling Pan; Palak P Amin; Ying Li; Qingxian Lu; Junying Yuan
Journal:  Mol Cell       Date:  2019-06-20       Impact factor: 17.970

2.  Flotillin-mediated endocytosis and ALIX-syntenin-1-mediated exocytosis protect the cell membrane from damage caused by necroptosis.

Authors:  Weiliang Fan; Jia Guo; Beichen Gao; Wenbin Zhang; Liucong Ling; Tao Xu; Chenjie Pan; Lin Li; She Chen; Hua Wang; Jing Zhang; Xiaodong Wang
Journal:  Sci Signal       Date:  2019-05-28       Impact factor: 8.192

3.  MLKL, the Protein that Mediates Necroptosis, Also Regulates Endosomal Trafficking and Extracellular Vesicle Generation.

Authors:  Seongmin Yoon; Andrew Kovalenko; Konstantin Bogdanov; David Wallach
Journal:  Immunity       Date:  2017-06-27       Impact factor: 31.745

4.  Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase.

Authors:  Liming Sun; Huayi Wang; Zhigao Wang; Sudan He; She Chen; Daohong Liao; Lai Wang; Jiacong Yan; Weilong Liu; Xiaoguang Lei; Xiaodong Wang
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

5.  The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism.

Authors:  James M Murphy; Peter E Czabotar; Joanne M Hildebrand; Isabelle S Lucet; Jian-Guo Zhang; Silvia Alvarez-Diaz; Rowena Lewis; Najoua Lalaoui; Donald Metcalf; Andrew I Webb; Samuel N Young; Leila N Varghese; Gillian M Tannahill; Esme C Hatchell; Ian J Majewski; Toru Okamoto; Renwick C J Dobson; Douglas J Hilton; Jeffrey J Babon; Nicos A Nicola; Andreas Strasser; John Silke; Warren S Alexander
Journal:  Immunity       Date:  2013-09-05       Impact factor: 31.745

6.  Biological events and molecular signaling following MLKL activation during necroptosis.

Authors:  Yi-Nan Gong; Cliff Guy; Jeremy Chase Crawford; Douglas R Green
Journal:  Cell Cycle       Date:  2017-08-30       Impact factor: 4.534

7.  ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences.

Authors:  Yi-Nan Gong; Cliff Guy; Hannes Olauson; Jan Ulrich Becker; Mao Yang; Patrick Fitzgerald; Andreas Linkermann; Douglas R Green
Journal:  Cell       Date:  2017-04-06       Impact factor: 41.582

8.  Mixed Lineage Kinase Domain-like Protein MLKL Breaks Down Myelin following Nerve Injury.

Authors:  Zhengxin Ying; Chenjie Pan; Tianyu Shao; Liqing Liu; Lin Li; Dejia Guo; Sitao Zhang; Tianyi Yuan; Ran Cao; Zhaodi Jiang; She Chen; Fengchao Wang; Xiaodong Wang
Journal:  Mol Cell       Date:  2018-10-18       Impact factor: 17.970

9.  Oligomerization-driven MLKL ubiquitylation antagonizes necroptosis.

Authors:  Zikou Liu; Laura F Dagley; Kristy Shield-Artin; Samuel N Young; Aleksandra Bankovacki; Xiangyi Wang; Michelle Tang; Jason Howitt; Che A Stafford; Ueli Nachbur; Cheree Fitzgibbon; Sarah E Garnish; Andrew I Webb; David Komander; James M Murphy; Joanne M Hildebrand; John Silke
Journal:  EMBO J       Date:  2021-10-26       Impact factor: 11.598

10.  Ubiquitylation of MLKL at lysine 219 positively regulates necroptosis-induced tissue injury and pathogen clearance.

Authors:  Laura Ramos Garcia; Tencho Tenev; Richard Newman; Rachel O Haich; Gianmaria Liccardi; Sidonie Wicky John; Alessandro Annibaldi; Lu Yu; Mercedes Pardo; Samuel N Young; Cheree Fitzgibbon; Winnie Fernando; Naomi Guppy; Hyojin Kim; Lung-Yu Liang; Isabelle S Lucet; Andrew Kueh; Ioannis Roxanis; Patrycja Gazinska; Martin Sims; Tomoko Smyth; George Ward; John Bertin; Allison M Beal; Brad Geddes; Jyoti S Choudhary; James M Murphy; K Aurelia Ball; Jason W Upton; Pascal Meier
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.